Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma


Ingels A., Campi R., Capitanio U., Amparore D., Bertolo R., Carbonara U., ...Daha Fazla

NATURE REVIEWS UROLOGY, cilt.19, sa.7, ss.391-418, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 19 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1038/s41585-022-00592-3
  • Dergi Adı: NATURE REVIEWS UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.391-418
  • İstanbul Üniversitesi Adresli: Evet

Özet

Standard-of-care management of renal cell carcinoma (RCC) relies on surgery for low-risk localized disease and systemic treatment for poor-prognosis metastatic tumours, but patients with high-risk localized tumours and with metastatic disease that has a good-to-intermediate prognosis are in a grey area for treatment. In this Review, the authors provide a comprehensive overview of the current knowledge on surgery and systemic treatment in the management of metastatic and localized RCC.